IE832896L - Pharmaceutical composition. - Google Patents

Pharmaceutical composition.

Info

Publication number
IE832896L
IE832896L IE832896A IE289683A IE832896L IE 832896 L IE832896 L IE 832896L IE 832896 A IE832896 A IE 832896A IE 289683 A IE289683 A IE 289683A IE 832896 L IE832896 L IE 832896L
Authority
IE
Ireland
Prior art keywords
pharmaceutically acceptable
molecular weight
pharmaceutical composition
compositions
gb2131691a
Prior art date
Application number
IE832896A
Other versions
IE56366B1 (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE832896L publication Critical patent/IE832896L/en
Publication of IE56366B1 publication Critical patent/IE56366B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Novel pharmaceutical compositions comprising i) an hydrogenated ergot alkaloid having vaso-constrictor activity, for example dihydroergotamine, or a pharmaceutically acceptable acid addition salt thereof and ii) a low molecular weight heparin or pharmaceutically acceptable salt thereof, and process for their production. Components ii) suitably have an average molecular weight of less than 10,000. The compositions are especially useful in the prevention of post-operative thrombosis. [GB2131691A]
IE2896/83A 1982-12-10 1983-12-09 Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin IE56366B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3245695 1982-12-10

Publications (2)

Publication Number Publication Date
IE832896L true IE832896L (en) 1984-06-10
IE56366B1 IE56366B1 (en) 1991-07-03

Family

ID=6180290

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2896/83A IE56366B1 (en) 1982-12-10 1983-12-09 Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin

Country Status (25)

Country Link
JP (1) JPH0672101B2 (en)
AT (1) AT382514B (en)
AU (1) AU570658B2 (en)
BE (1) BE898356A (en)
CA (1) CA1224416A (en)
CH (1) CH656533A5 (en)
CY (1) CY1509A (en)
DD (1) DD215469B3 (en)
DK (1) DK162475C (en)
FR (1) FR2537435B1 (en)
GB (1) GB2131691B (en)
GR (1) GR79745B (en)
HK (1) HK23290A (en)
HU (1) HU190513B (en)
IE (1) IE56366B1 (en)
IL (1) IL70406A (en)
IT (1) IT1172368B (en)
LU (1) LU85127A1 (en)
NL (1) NL8304221A (en)
NZ (1) NZ206523A (en)
PH (1) PH23451A (en)
PT (1) PT77803B (en)
SE (1) SE468973B (en)
SG (1) SG53989G (en)
ZA (1) ZA839200B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432661A1 (en) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger CARCINOM THERAPEUTIC
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1245761B (en) * 1991-01-30 1994-10-14 Alfa Wassermann Spa PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809618A1 (en) * 1978-03-06 1979-09-20 Sandoz Ag NEW THERAPEUTIC PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
SE441142B (en) * 1975-12-04 1985-09-16 Sandoz Ag PROCEDURE FOR PREPARING A THERAPEUTIC PREPARATION WITH ANTITHROMOBOTIC PROPERTIES
DE2554533C3 (en) * 1975-12-04 1984-08-30 Sandoz-Patent-Gmbh, 7850 Loerrach Use of dihydroergotamine and heparin
DE3020895A1 (en) * 1979-06-12 1980-12-18 Sandoz Ag ERGOPEPTIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE ERGOPEPTIN DERIVATIVES
DE2945636A1 (en) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach STABLE SOLUTIONS OF HYDRATED ERGOTAL CALOIDS OR YOUR SALTS AND HEPARIN OR ITS SALTS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
PT77803B (en) 1986-04-17
PH23451A (en) 1989-08-07
GB8332653D0 (en) 1984-01-11
PT77803A (en) 1984-01-01
CH656533A5 (en) 1986-07-15
DD215469A5 (en) 1984-11-14
IL70406A (en) 1988-08-31
CY1509A (en) 1990-08-03
DK162475B (en) 1991-11-04
GB2131691B (en) 1986-12-03
JPS59116222A (en) 1984-07-05
NL8304221A (en) 1984-07-02
ZA839200B (en) 1985-07-31
JPH0672101B2 (en) 1994-09-14
HUT34124A (en) 1985-02-28
ATA428483A (en) 1986-08-15
NZ206523A (en) 1987-04-30
SE8306792L (en) 1984-06-11
IL70406A0 (en) 1984-03-30
AU570658B2 (en) 1988-03-24
BE898356A (en) 1984-06-04
IT1172368B (en) 1987-06-18
LU85127A1 (en) 1984-10-22
FR2537435B1 (en) 1987-03-20
SE8306792D0 (en) 1983-12-08
CA1224416A (en) 1987-07-21
IT8349456A0 (en) 1983-12-07
FR2537435A1 (en) 1984-06-15
DK565783D0 (en) 1983-12-08
GB2131691A (en) 1984-06-27
SG53989G (en) 1989-12-29
DK162475C (en) 1992-05-11
SE468973B (en) 1993-04-26
AT382514B (en) 1987-03-10
DD215469B3 (en) 1988-03-09
AU2222183A (en) 1984-06-14
GR79745B (en) 1984-10-31
IT8349456A1 (en) 1985-06-07
HU190513B (en) 1986-09-29
HK23290A (en) 1990-04-06
DK565783A (en) 1984-06-11
IE56366B1 (en) 1991-07-03

Similar Documents

Publication Publication Date Title
CA2118219A1 (en) Preparations of low molecular weight hyaluronic acid for stimulating bone formation
NZ224275A (en) Low molecular weight heparin derivatives; pharmaceutical compositions
CA2011171A1 (en) Biodegradable Poly (Phosphate Esters)
HUT51254A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising same as active ingredient
IE900637L (en) Novel compositions containing hyaluronic acid associates and¹a process for preparing same
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
IE822610L (en) Amorphous soluble medicaments
AU2348988A (en) 4H-1-benzopyran-4-one derivative or its salt, processes for producing the same and pharmaceutical composition comprising the same as active ingredient
AU2691488A (en) Pyrimidine derivatives, processes for their production, and herbicidal method and compositions
HU9401411D0 (en) Bile acid derivatives, process for producing them and pharmaceutical compositions containing them
AU2471788A (en) Pyrimidine derivatives, processes for their production, and herbicidal method and compositions
HUT46654A (en) Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient
AU3091489A (en) Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
IL95503A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
HUT61196A (en) Process for producing pharmaceutical composition which may be dropped in the eye
CA2253833A1 (en) Derivatives of k5 polysaccharide having high anticoagulant activity
AU4469197A (en) Pharmaceutical compositions with antimicrobial activity
HUT61554A (en) Process for producing 2,8-dioxabicyclo/3.2.1/octane derivatives and pharmaceutical compositions comprising same
AU5185886A (en) Stable dispersions of polyureas and/or polyhydrazodi- carbonamides in relatively high molecular weight, hydroxyl group containing compounds, process for the production thereof and use thereof for the production of polyurethanes
CA2017851A1 (en) Micronised biodegradable particles, process for preparing them and the use thereof
HUT53363A (en) Process for producing new perhydroazacycloalkano(1,2-a)imidazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT54671A (en) Process for producing benzothiopirane derivatives and pharmaceutical compositions containing them as active component
HUT50112A (en) Process for producing phenoxyalkyl-carboxylic acid derivatives and pharmaceutical compositions containing them as active component
AU7508087A (en) New 4-pyridone derivatives, method of their production and their pharmaceutical compositions
EP0475383A3 (en) Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient

Legal Events

Date Code Title Description
MM4A Patent lapsed